3
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6047 |
Ralimetinib dimesylate
LY2228820 dimesylate,Ralimetinib,LY2228820,Ralimetinib Mesylate |
Apoptosis; p38 MAPK; Autophagy | Apoptosis; Autophagy; MAPK |
Ralimetinib dimesylate (LY2228820 dimesylate) 是一种选择性,ATP 竞争性的 p38 MAPK α/β抑制剂,IC50分别为5.3 和 3.2 nM。 | |||
T16721 |
Ralimetinib
LY2228820 |
Others | Others |
Ralimetinib selectively inhibits phosphorylation of MK2 (Thr334) and has no effect on phosphorylation of p38α MAPK, JNK, ERK1/2, c-Jun, ATF2, or c-Myc. Ralimetinib is an effective and selective, ATP-competitive inhibitor of p38 MAPK α/β (IC50s: 5.3 and 3. | |||
T124008 |
6-Formyllimetin
|
||
6-Formyllimetin 是一种有用的有机化合物,可用于生命科学领域的相关研究,其产品编号为 T124008。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2852 |
Citropten
Limettin,Citroptene,Limetin,5, 7-Dimethoxycoumarin,柠美内脂,5,7-二甲氧基香豆素,5,7-Dimethoxycoumarin |
Others | Others |
Citropten (Limetin) 是一种香豆素,分离自佛手柑油中,对 A2058 人黑色素瘤细胞株具有抗增殖作用。 |